Indian Aurobindo Readies API Factory For Japanese Market
This article was originally published in PharmAsia News
Amid a wave of Indian pharmaceutical makers increasing exports to Japan, Aurobindo Pharma Ltd is getting ready to commence operations of its new active ingredient plant that is wholly devoted to the Japanese market.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.